NASDAQ · Medical - Devices

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock

$11.58 +1.22% NASDAQ: LMRI Healthcare

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States.

Valuation

MetricValue
Price$11.58
Market Cap$1.11B
P/E Ratio-31.98
P/B Ratio1.85
P/S Ratio2.14
EPS (TTM)$-0.66
52-Week High$19.45
52-Week Low$6.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.98%
ROA-1.53%
ROCE-0.18%
Gross Margin10.49%
Operating Margin-0.57%
Net Margin-5.18%
Debt/Equity1.61
Current Ratio1.40

Annual Financials (USD)

Metric202320242025
Revenue$936.0M$949.0M$1.0B
Operating Profit$22.0M$55.0M$27.0M
Net Profit$-122.0M$-94.0M$-47.0M
EPS$-1.29$-1.00$-0.66
Op Margin2.4%5.8%2.6%

Balance Sheet (USD)

Metric202320242025
Total Assets$1.7B$1.7B$1.8B
Total Liabilities$1.5B$1.5B$1.2B
Cash$20.0M$26.0M$59.0M
Borrowings$1.3B$1.3B$963.0M

Latest News

Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway Zacks · Jul 21, 2026 Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet Zacks · Jul 13, 2026 UG Outperforms Industry in 6 Months: Buy, Sell or Hold the Stock? Zacks · Jul 8, 2026 Lumexa Imaging Refinances Debt MT Newswires · Jul 1, 2026 Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade Zacks · Jun 25, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$38.0M$41.0M$17.0M
Investing Cash Flow$-54.0M$-50.0M$-44.0M
Financing Cash Flow$0$-1.0M$2.0M
Net Cash Flow$-1.0M$6.0M$33.0M
Free Cash Flow$14.0M$13.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.32
EV / EBITDA42.06
FCF Yield0.93%
Quick Ratio1.40
Interest Coverage-0.07
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held80.79%
Institutions Held34.61%
Institutions Float Held180.11%
Institutional HolderSharesReport Date
Alliancebernstein L.P.2,980,4622026-03-31
Massachusetts Financial Services Co.2,334,5802026-03-31
Janus Henderson Group PLC2,100,3562026-03-31
Brown Advisory Inc.1,705,0772026-03-31
ArrowMark Colorado Holdings LLC1,653,2582026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSXBoston Scientific Corporation $46.04 -0.04% 22.56 $68.43B 0.00%
BWAYBrainsWay Ltd. $16.56 +2.54% 72.48 $649.53M 0.00%
CODX $2.04 -2.86% -0.11 $2.28M 0.00%
INSP $50.93 +3.54% 8.73 $1.47B 0.00%
IRTC $112.15 +2.70% 113.40 $3.69B 0.00%

About Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

Lumexa Imaging Holdings, Inc. Common Stock is led by CEO Caitlin Zulla, headquartered in US, publicly traded since 2025.

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) stock trades at $11.58 with a market capitalization of $1.11B. The stock is valued at a price-to-earnings (P/E) ratio of -31.98, price-to-book of 1.85, price-to-sales of 2.14. Over the past 52 weeks the stock has ranged between $6.45 and $19.45, and currently trades 40.5% below its 52-week high.

On profitability, Lumexa Imaging Holdings, Inc. Common Stock generates a return on equity (ROE) of -5.98%, return on capital employed of -0.18%, an operating margin of -0.57%, a net profit margin of -5.18%.

Official website: www.lumexaimaging.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides